- Release Date: 11/09/13 10:08
- Summary: Viralytics receives MHRA approval for UK Clinical Trial
- Price Sensitive: Yes
- Download Document 173.97KB
- Forums
- ASX - By Stock
- Ann: Viralytics receives MHRA approval for UK Cli
Ann: Viralytics receives MHRA approval for UK Cli
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity